When Screening for Prostate Cancer Comes Too Late September 4, 2023 Over the years, recommendations for prostate cancer screening have fluctuated due to concerns about over-treatment and side effects. While the U.S. Preventive Services Task Force initially advised against routine screening in 2012, it later recommended considering it for men aged 55 to 69 after consultations with doctors. However, this pendulum swing has led to more late-stage prostate cancer diagnoses, stalling a two-decade decline in death rates. The challenge lies in balancing the risks of overdiagnosis with the opportunity to detect and treat the disease effectively, particularly among high-risk groups. Medical experts and organizations are now working to refine screening guidelines, aiming to better target at-risk individuals and utilize improved diagnostic tools while considering treatment advances and diverse patient populations.Read the full article by the Wall Street Journal here. Read More About Prostate Cancer Enjoy our library of additional news articles, our Journey to ZERO blog, and our ZEROHour newsletter. ZERO in the News ZERO in the News Read features about ZERO Prostate Cancer in the news—covering events, personal stories, advocacy efforts, and more! ZEROHour ZEROHour ZEROHour features news about prostate cancer, updates on ZERO’s initiatives and activities, and featured stories of those impacted by the disease. Journey to ZERO Journey to ZERO Our Journey to ZERO blog features commentary and discussion about what's happening in the prostate cancer community, stories and inspiration from people impacted by the disease, and insights on news and current events. About Prostate Cancer Prostate Cancer News Screening & PSA Test Testing & Diagnosis Contributor Brianna Abbott, Health Reporter Brianna Abbott is a health reporter covering the treatment and prevention of disease, with a special focus on cancer, in The Wall Street Journal’s Health and Science bureau. She writes stories about cutting-edge scientific research, patient care, and public health. She also covers health and screening recommendations and the agencies that produce them. In 2023, she and her colleagues won a New York Press Club Award in the Feature-Science Medicine & Technology category for their Covid-19 coverage. Previously, she attended the Science, Health and Environmental Reporting Program at New York University and studied chemistry and creative writing at Providence College in Rhode Island. Brianna joined the Journal in 2019 following an internship with the newspaper. Source: The Wall Street Journal Learn more about Brianna More for you
Over the years, recommendations for prostate cancer screening have fluctuated due to concerns about over-treatment and side effects. While the U.S. Preventive Services Task Force initially advised against routine screening in 2012, it later recommended considering it for men aged 55 to 69 after consultations with doctors. However, this pendulum swing has led to more late-stage prostate cancer diagnoses, stalling a two-decade decline in death rates. The challenge lies in balancing the risks of overdiagnosis with the opportunity to detect and treat the disease effectively, particularly among high-risk groups. Medical experts and organizations are now working to refine screening guidelines, aiming to better target at-risk individuals and utilize improved diagnostic tools while considering treatment advances and diverse patient populations.Read the full article by the Wall Street Journal here.
Read More About Prostate Cancer Enjoy our library of additional news articles, our Journey to ZERO blog, and our ZEROHour newsletter. ZERO in the News ZERO in the News Read features about ZERO Prostate Cancer in the news—covering events, personal stories, advocacy efforts, and more! ZEROHour ZEROHour ZEROHour features news about prostate cancer, updates on ZERO’s initiatives and activities, and featured stories of those impacted by the disease. Journey to ZERO Journey to ZERO Our Journey to ZERO blog features commentary and discussion about what's happening in the prostate cancer community, stories and inspiration from people impacted by the disease, and insights on news and current events.
